Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.49
- Piotroski Score 7.00
- Grade Buy
- Symbol (TARO)
- Company Taro Pharmaceutical Industries Ltd.
- Price $42.98
- Changes Percentage (0.01%)
- Change $0.01
- Day Low $42.94
- Day High $42.98
- Year High $45.76
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
- Last Earnings 11/05/2018
- Ex-Dividend for 5/16 Dividend 12/10/2018
- Dividend Payable 12/28/2018
- Today N/A
- Next Earnings (Estimated) 07/24/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.43
- Trailing P/E Ratio 29.91
- Forward P/E Ratio 29.91
- P/E Growth 29.91
- Net Income $53.87 M
Income Statement
Quarterly
Annual
Latest News of TARO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Japanese poet Shuntaro Tanikawa, master of modern free verse, has died at 92
Renowned Japanese poet Shuntaro Tanikawa, known for his innovative and conversational style, has passed away at 92. His works, including "Two Billion Light Years of Solitude," resonated globally....
By AP NEWS | 2 days ago -
Wizz Air loses challenge against EU-approved Romanian aid for TAROM
Wizz Air lost its challenge against Romanian TAROM's capital increase funded by Romania and approved by EU regulators. The Luxembourg court dismissed Wizz Air's arguments, upholding the aid's compatib...
By Yahoo! Finance | 2 weeks ago -
Kentaro Sakaguchi Has What It Takes To Be A K-Drama Leading Man
Kentaro Sakaguchi plays Jungo Aoki in the k-drama What Comes After Love, where he portrays a Japanese novelist falling in love with a Korean woman. Despite limited Korean skills, Sakaguchi learned the...
By Forbes | 2 weeks ago
